Shinshu University HOMEJAPANESEAccess / Campus Map

Shinshu University Researcher DirectoryShinshu University Researcher Directory

Search by Researcher / Research Field
Search by Category

JOSHITA Satoru

Academic OrganizationAcademic Assembly School of Medicine and Health Sciences Institute of MedicineTEL
Education and Research OrganizationSchool of Medicine Department of Medicine 2FAX
PositionAssistant ProfessorMail Address
AddressAsahi 3-1-1 Matsumoto, NaganoWeb site

Profile

Research Field
Medicine
Gastroenterology
Academic Background
Graduate School
Shinshu University Graduate School of Medicine , 2010

College
Niigata University School of Medicine , 2002

Degree
PhD (Medicine) , Shinshu University (Japan)

Research

Books, Articles, etc.
Articles
Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct-acting antivirals: A case report.
J Dermatol. ,46(5):e149-e151 2018(Nov. 03)
Author:Nihei T, Kiniwa Y, Mikoshiba Y, Joshita S, Okuyama R.


Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C.
Cytokine,111(1):357-363 2018(Oct. 05)
Author:Umemura T, Yamazaki T, Joshita S, Sugiura A, Fujimori N, Matsumoto A, Ota M, Tanaka E.


Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.
J Viral Hepat,25(12):1462-1471 2018(Aug. 30)
Author:Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E.


Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients.
Hepatol Res,48(13):1092-1098 2018(Jul. 27)
Author:Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E.


KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.
Oncotarget,9(28):19650-19661 2018(Apr. 13)
Author:Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M.


Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
J Gastroenterol.,53(9):1079-1088 2018(Feb. 23)
Author:Joshita S, Yoshizawa K, Umemura T, et al.


Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development.
Science,359(6381):1269-1273 2018(Feb. 01)
Author:Vainchtein ID, Chin G, Cho FS, Kelley KW, Miller JG, Chien EC, Liddelow SA, Nguyen PT, Nakao-Inoue H, Dorman LC, Akil O, Joshita S, Barres BA, Paz JT, Molofsky AB, Molofsky AV.


Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism.
J Exp Med.,215(3):745-760 2018(Jan. 10)
Author:Song WM, Joshita S, Zhou Y, et al.


A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis.
Sci Rep,8(1):11924 2018
Author:Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M.


Salmonella Enteritidis cholecystitis with chronic granulomatous disease.
IDCases,12(1):49-52 2018
Author:Yamashita Y, Kimura T, Tanaka N, Yazaki M, Itagaki T, Joshita S, Umemura T, Matsumoto A, Mori H, Wada S, Tanaka E.


Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.
Sci Rep,8(1):8159 2018
Author:Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E.


Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
PLOS ONE,13(4):e0195778 2018
Author:Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M.


Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
World J Gastroenterol. ,24(13):1440-1450 2018
Author:Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E.


Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.
PLoS One,13(4):e0195632 2018
Author:Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E.


Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.
World J Gastroenterol.,24(11):1239-1249 2018
Author:Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E.


A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature.
J Infect Chemother.,24(5):393-397 2017(Dec. 18)
Author:Yamazaki T, Joshita S, Kasuga E, et al.


Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection.
Hepatol Res.,48(4):275-285 2017(Dec. 04)
Author:Joshita S, Ichikawa Y, Umemura T, et al.


Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.
Clin J Gastroenterol.,11(1):11-18 2017(Nov. 20)
Author:Joshita S, Umemura T, Tanaka E, Ota M.


Association between lower air pressure and the onset of ischemic colitis: a case-control study
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,29(9):1071-1078 2017(Sep.)
Author:Kimura, Takefumi; Shinji, Akihiro; Tanaka, Naoki; Koinuma, Masayoshi; Yamaura, Maki; Nagaya, Tadanobu; Joshita, Satoru; Komatsu, Michiharu; Umemura, Takeji; Horiuchi, Akira; Wada, Shuichi; Tanaka, Eiji;


Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
LIVER INTERNATIONAL,37(6):897-905 2017(Jun.)
Author:Umemura, Takeji; Sekiguchi, Tomohiro; Joshita, Satoru; Yamazaki, Tomoo; Shibata, Soichiro; Ichikawa, Yuki; Komatsu, Michiharu; Matsumoto, Akihiro; Shums, Zakera; Norman, Gary L.; Tanaka, Eiji; Ota, Masao;


Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
HEPATOLOGY RESEARCH,47(5):405-418 2017(Apr.)
Author:Kimura, Takefumi; Kobayashi, Akira; Tanaka, Naoki; Sano, Kenji; Komatsu, Michiharu; Fujimori, Naoyuki; Yamazaki, Tomoo; Shibata, Soichiro; Ichikawa, Yuki; Joshita, Satoru; Umemura, Takeji; Matsumoto, Akihiro; Horiuchi, Akira; Mori, Hiromitsu; Wada, Shuichi; Kiyosawa, Kendo; Miyagawa, Shin-ichi; Tanaka, Eiji;


Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
HEPATOLOGY RESEARCH,47(2):226-233 2017(Feb.)
Author:Ichikawa, Yuki; Joshita, Satoru; Umemura, Takeji; Shobugawa, Yugo; Usami, Yoko; Shibata, Soichiro; Yamazaki, Tomoo; Fujimori, Naoyuki; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji;


Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.
Hum Mol Genet,in press 2017(Jan.)
Author:Kawashima M, Hitomi Y, Aiba Y, Nishida N, Kojima K, Kawai Y, Nakamura H, Tanaka A, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Abe M, Nakao K, Yamagiwa S, Kaneko S, Honda M, Umemura T, Ichida T, Seike M, Sakisaka S, Harada M, et al.


Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
JOURNAL OF IMMUNOLOGY RESEARCH,:- 2017
Author:Joshita, Satoru; Umemura, Takeji; Tanaka, Eiji; Ota, Masao;


Association between endotoxemia and histological features of nonalcoholic fatty liver disease
WORLD JOURNAL OF GASTROENTEROLOGY,23(4):712-722 2017
Author:Kitabatake, Hiroyuki; Tanaka, Naoki; Fujimori, Naoyuki; Komatsu, Michiharu; Okubo, Ayaka; Kakegawa, Kyogo; Kimura, Takefumi; Sugiura, Ayumi; Yamazaki, Tomoo; Shibata, Soichiro; Ichikawa, Yuki; Joshita, Satoru; Umemura, Takeji; Matsumoto, Akihiro; Koinuma, Masayoshi; Sano, Kenji; Aoyama, Toshifumi; Tanaka, Eiji;


Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
Liver Int,in press 2016(Nov.)
Author:Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M.


Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
Hepatol Res,46(9):884-9 2016(Aug.)
Author:Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E.


Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan.
Hepatol Res,46(9):878-83 2016(Aug.)
Author:Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M.


Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
Springerplus,5(1):998 2016(Jul.)
Author:Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E.


Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
Sci Rep,6:29770 2016(Jul.)
Author:Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, Tanaka E, Ota M.


Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Hepatol Res,in press 2016(Jun.)
Author:Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E.


Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Hepatol Res,in press 2016(Mar.)
Author:Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E.


Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease.
Dis Markers,2016:6485343 2016
Author:Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M.


Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Am J Gastroenterol,110(6):857-64 2015(Jun.)
Author:Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E.


Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
PLoS One,10(6):e0131658 2015(Jun.)
Author:Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M.


Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Biochim Biophys Acta,1852(3):473-81 2015(Mar.)
Author:Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T.


Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
PLOS ONE,9(6):e100565 2014(Jun.)
Author:Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M


STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
DISEASE MARKERS,2014:727393 2014
Author:Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M


Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
HUMAN IMMUNOLOGY,74(2):219-222 2013(Feb.)
Author:Morita, S; Joshita, S; Umemura, T; Katsuyama, Y; Kimura, T; Komatsu, M; Matsumoto, A; Yoshizawa, K; Kamijo, A; Yamamura, N; Tanaka, E; Ota, M


Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
INTERNAL MEDICINE,52(17):1903-1908 2013
Author:Sekiguchi, N; Joshita, S; Yoshida, T; Kurozumi, M; Sano, K; Nakagawa, M; Ito, T; Matsushita, T; Komatsu, D; Komatsu, M; Ito, T; Umemura, T; Ikeda, S; Kadoya, M; Ishida, F; Tanaka, E


Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
HEPATOLOGY RESEARCH,43(7):801-807 2013
Author:Joshita, S; Shirahata, K; Yazaki, Y; Okaniwa, S; Nakamura, Y; Kimura, T; Noami, S; Horigome, R; Yagi, H; Ito, N; Yamazaki, A; Akahane, Y; Umemura, T; Yoshizawa, K; Tanaka, E; Ota, M


Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers
Tissue Antigens,80(4):305-316 2012(Oct.)
Author:Shiina T, Suzuki S, Ozaki Y, Taira H, Kikkawa E, Shigenari A, Oka A, Umemura T, Joshita S, Takahashi O, Hayashi Y, Paumen M, Katsuyama Y, Mitsunaga S, Ota M, Kulski JK, Inoko H


Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population
Am J Hum Genet,91(4):721-728 2012(Oct.)
Author:Nakamura M, Nishida N, Kawashima M, Aiba Y, Tanaka A, Yasunami M, Nakamura H, Komori A, Nakamuta M, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Onji M, Kaneko S, Honda M, Yamagiwa S, Nakao K, Ichida T, Takikawa H, Seike M, Umemura T, Ueno Y, Sakisaka S, Kikuchi K, Ebinuma H, Yamashiki N, Tamura S, Sugawara Y, Mori A, Yagi S, Shirabe K, Taketomi A, Arai K, Monoe K, Ichikawa T, Taniai M, Miyake Y, Kumagi T, Abe M, Yoshizawa K, Joshita S, Shimoda S, Honda K, Takahashi H, Hirano K, Takeyama Y, Harada K, Migita K, Ito M, Yatsuhashi H, Fukushima N, Ota H, Komatsu T, Saoshiro T, Ishida J, Kouno H, Kouno H, Yagura M, Kobayashi M, Muro T, Masaki N, Hirata K, Watanabe Y, Nakamura Y, Shimada M, Hirashima N, Komeda T, Sugi K, Koga M, Ario K, Takesaki E, Maehara Y, Uemoto S, Kokudo N, Tsubouchi H, Mizokami M, Nakanuma Y, Tokunaga K, Ishibashi H


Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
J Gastroenterol,47(9):1006-1013 2012(Sep.)
Author:Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S


Long-term outcome of Japanese patients with type 1 autoimmune hepatitis
Hepatology,56(2):668-676 2012(Aug.)
Author:Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M


Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
HUMAN IMMUNOLOGY,73(3):298-300 2012(Mar.)
Author:Joshita, Satoru; Umemura, Takeji; Katsuyama, Yoshihiko; Ichikawa, Yuki; Kimura, Takefumi; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Kamijo, Nozomi; Ota, Masao; Tanaka, Eiji


Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
Hepatology,55(2):506-511 2012(Feb.)
Author:Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M, Shinshu PBC Study Group


Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
Antivir Ther,16(7):1073-1080 2011(Oct.)
Author:Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E


Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients
J Gastroenterol,46(10):1203-1212 2011(Oct.)
Author:Aiba Y, Nakamura M, Joshita S, Inamine T, Komori A, Yoshizawa K, Umemura T, Horie H, Migita K, Yatsuhashi H, Nakamuta M, Fukushima N, Saoshiro T, Hayashi S, Kouno H, Ota H, Muro T, Watanabe Y, Nakamura Y, Komeda T, Shimada M, Masaki N, Komatsu T, Yagura M, Sugi K, Koga M, Tsukamoto K, Tanaka E, Ishibashi H, NHOSLJ PBCSGi


Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
Hepatol Res,41(9):904-909 2011(Sep.)
Author:Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E


A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
Intern Med,50(17):1815-1819 2011(Sep.)
Author:Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E


Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Hepatol Res,41(6):587-593 2011(Jun.)
Author:Yoneda S, Umemura T, Joshita S, Ichijo T, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E


Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
Hepatol Res,41(4):350-357 2011(Apr.)
Author:Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E


Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients
J Infect Dis,203(8):1087-1095 2011(Mar.)
Author:Yoneda S, Umemura T, Katsuyama Y, Kamijo A, Joshita S, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E


Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
J Gastroenterol,46 Suppl 1:48-55 2011(Jan.)
Author:Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E


Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
JOURNAL OF GASTROENTEROLOGY,45(12):1263-1271 2010(Dec.)
Author:Hatta, Tomoko; Fujinaga, Yasunari; Kadoya, Masumi; Ueda, Hitoshi; Murayama, Hiroaki; Kurozumi, Masahiro; Ueda, Kazuhiko; Komatsu, Michiharu; Nagaya, Tadanobu; Joshita, Satoru; Kodama, Ryo; Tanaka, Eiji; Uehara, Tsuyoshi; Sano, Kenji; Tanaka, Naoki


Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients
JOURNAL OF HEPATOLOGY,53(3):537-541 2010(Sep.)
Author:Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Nakamura, Minoru; Ishibashi, Hiromi; Ota, Masao


Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
JOURNAL OF CLINICAL GASTROENTEROLOGY,44(6):440-447 2010(Jun.)
Author:Tsutsui, Masaru; Tanaka, Naoki; Kawakubo, Masatomo; Sheena, Yo; Horiuchi, Akira; Komatsu, Michiharu; Nagaya, Tadanobu; Joshita, Satoru; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji; Sano, Kenji


A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
HUMAN IMMUNOLOGY,71(5):520-524 2010(May)
Author:Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao


A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry
JOURNAL OF KOREAN MEDICAL SCIENCE,25(3):476-480 2010(Mar.)
Author:Joshita, Satoru; Nakazawa, Koh; Koike, Shoichiro; Kamijo, Atsushi; Matsubayashi, Kiyoshi; Miyabayashi, Hideharu; Furuta, Kiyoshi; Kitano, Kiyoshi; Yoshizawa, Kaname; Tanaka, Eiji


A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
INTERNAL MEDICINE,49(11):991-994 2010
Author:Joshita, Satoru; Yoshizawa, Kaname; Sano, Kenji; Kobayashi, Satoshi; Sekiguchi, Tomohiro; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Tanaka, Eiji


A case of well-differentiated cholangiolocellular carcinoma visualized with contrast-enhanced ultrasonography using Sonazoid
HEPATOLOGY RESEARCH,39(2):207-212 2009(Feb.)
Author:Joshita, Satoru; Ichijo, Tetsuya; Suzuki, Fumitaka; Yokoyama, Takahide; Sugiyama, Yukiko; Fukushima, Mana; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Yoshizawa, Kaname; Miyagawa, Shinichi; Tanaka, Eiji


Primitive Neuroectodermal Tumor as a Differential Diagnosis of CD56-Positive Tumors in Adults
INTERNAL MEDICINE,48(15):1267-1272 2009
Author:Nagaya, Tadanobu; Tanaka, Naoki; Kamijo, Atsushi; Joshita, Satoru; Nakazawa, Koh; Miyabayashi, Hideharu; Yoneda, Suguru; Ito, Tetsuya; Komatsu, Michiharu; Tanaka, Eiji; Kitano, Kiyoshi


Granulocyte-Colony Stimulating Factor-Producing Pancreatic Adenosquamous Carcinoma Showing Aggressive Clinical Course
INTERNAL MEDICINE,48(9):687-691 2009
Author:Joshita, Satoru; Nakazawa, Koh; Sugiyama, Yukiko; Kamijo, Atsushi; Matsubayashi, Kiyoshi; Miyabayashi, Hideharu; Furuta, Kiyoshi; Kitano, Kiyoshi; Kawa, Shigeyuki


Zygomycosis presenting as acute myocardial infarction during hematological malignancies
INTERNAL MEDICINE,47(9):839-842 2008
Author:Joshita, Satoru; Kitano, Kiyoshi; Nagaya, Tadanobu; Kamijo, Atsushi; Nakazawa, Koh; Ishida, Fumihiro


Presentations
DOWN-REGULATION OF SREBP-1C IS ASSOCIATED WITH THE DEVELOPMENT OF BURNED-OUT NASH
the European Association for the Study of the Liver , JOURNAL OF HEPATOLOGY , 52:S373-S374 2010
Author:Nagaya, T.; Tanaka, N.; Komatsu, M.; Joshita, S.; Umemura, T.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Aoyama, T.; Tanaka, E.